Koers Genesis Healthcare, Inc. Other OTC
Aandelen
GEN
US37185X1063
Gezondheidszorgvoorzieningen & -diensten
Omzet 2021 * | 3,46 mld. 3,24 mld. | Omzet 2022 * | - | Marktkapitalisatie | 134K 125K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 * | -22 mln. -20,58 mln. | Nettowinst (verlies) 2022 * | - | EV/omzet 2021 * | 0,95 x |
Nettoschuld 2021 * | 3,28 mld. 3,06 mld. | Nettoliquiditeiten 2022 * | - 0 | EV/omzet 2022 * | - |
K/w-verhouding 2021 * |
-0,01
x | K/w-verhouding 2022 * |
-
| Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 * |
-
| Vrij verhandelbaar | 46,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 01-02-21 | |
Public Communications Contact | - | - | |
Susan Overton
LAW | General Counsel | - | 01-01-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 72 | 02-02-15 | |
John Randazzo
BRD | Director/Board Member | 69 | 02-03-21 |
Chairman | 79 | 02-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,92% | 84,68 mld. | |
+13,30% | 81,12 mld. | |
+10,92% | 29,4 mld. | |
-12,71% | 16,73 mld. | |
-3,06% | 16,36 mld. | |
-2,63% | 14,92 mld. | |
-3,97% | 11,66 mld. | |
-1,42% | 11,72 mld. | |
-31,75% | 11,77 mld. |